Sid Sijbrandij Cancer Journey

​Sid Sijbrandij reached the end of standard of care for his osteosarcoma. He did a combination of maximal diagnostics, experimental medicines, creating new medicines, and treatments in parallel to get rid of the cancer. He and Jacob Stern will share what they learned and their recommendations for making medicine more patient first.

​Doors open at 6:45am. Continental breakfast will be served. Seating available for the first 100 guests to RSVP.

​Talk and Q&A from 7:00–8:00am. The room will remain open until 10:00am for continued discussion and conversation.